Elena Roussak

Territory Manager Ophthalmics (Ab and Interior Bc) @SUN PHARMA

Calgary, AB, CA

Sun Pharmaceutical Industries Ltd.(Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US$ 5.4 billion. Supported by 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.Sun Pharma entered the Canadian market in 2015 with the purchase of Ranbaxy Laboratories Limited, a Top 10 generic company in Canada since 2005. In October, 2019 Sun Pharma announced the launch of CEQUA (cyclosporine ophthalmic solution) 0.09% in the U.S. CEQUA, which offers the highest concentration of cyclosporine for ophthalmic use approved by the U.S. Food and Drug Administration (FDA), is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye), an inflammatory disease. In addition to higher concentration of cyclosporine, CEQUA uses a proprietary delivery system, NCELL Technology, which acts to surround the active ingredient in CEQUA, cyclosporine and optimize penetration through layers of the tear film onto the ocular surface. In January, 2022 CEQUA was launched in Canada.With core ideologies of humility, integrity, passion, and innovation, Sun Pharma\'s continued goal is to provide our customers and partners with affordable, high quality products and exceptional customer service in Canada and around the world.

University of Manitoba

Bachelor of Commerce (B.Com.), Entrepreneurship/Entrepreneurial Studies